84-2270-91 ［取扱停止］BCL9 (B-Cell CLL/Lymphoma 9, Gm130) 100ul 218833
特徴
- BCL9 is associated with B-cell acute lymphoblastic leukemia.
- It may be a target of translocation in B-cell malignancies with abnormalities of 1q21.
- Its function is unknown.
- The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.
- (provided by RefSeq, Jul 2008)
- Applications:Suitable for use in Immunofluorescence, Western Blot.
- Other applications not tested.
- Recommended Dilution:Immunofluorescence: 1:50-1:200Western Blot: 1:500-1:2000Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size：100ul
- Host：rabbit
- Source Antibody：mouse
- Grade：Affinity Purified
- Purity：Purified by affinity chromatography.
- Form：Supplied as a liquid in PBS, pH 7.3, 0.02% sodium azide, 50% glycerol.
- Specificity：Recognizes mouse Bcl9. Species Crossreactivity: Human, rat
- Isotype：IgG
- Calc Applications Abbrev：IF WB
- Calc Crossreactivity：Hu Mo Rt
- Immunogen：Recombinant protein corresponding to mouse Bcl9.
- Shelf Life：1year
- Swiss Prot Number：O00512
- EU Commodity Code：30021010
- この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
